Status:
UNKNOWN
Efficacy and Safety Study of Ticagrelor
Lead Sponsor:
General Hospital of Chinese Armed Police Forces
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel
Detailed Description
180 elective percutaneous coronary intervention patients with clopidogrel resistance were randomized to three groups, Group 1:received clopidogrel 75mg qd ;Group 2:received clopidogrel 150mg qd ; Grou...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ACS 2.undergoing PCI 3.with clopidogrel resistance
Exclusion
- any contraindication against the use of clopidogrel and ticagrel 2.Contradiction to aspirin and contrast medium 3.Life expectancy less than 1 year 4.Tumor or inflammatory diseases5. fibrinolytic therapy within 24 hours before randomization 6.a need for oral anticoagulation therapy 7. an increased risk of bradycardia 8.concomitant therapy with a strong cytochrome P-450 3A inhibitor or inducer 9.a history of asthma.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01812330
Start Date
January 1 2013
End Date
July 1 2016
Last Update
June 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Chinese People's Armed Police Forces
Beijing, China, 100039